Back to top

Image: Bigstock

Albemarle (ALB) Set to be Added to the S&P 500 Index

Read MoreHide Full Article

Albemarle Corporation (ALB - Free Report) is slated to join the S&P 500 index after the market closes on Jun 30, 2016. The company is currently part of the S&P MidCap 400 index. Albemarle will be replacing TECO Energy Inc. in the S&P 500 index as the latter is set to be acquired by Emera Inc., a Canadian electric utility company.

The Baton Rouge, LA-based specialty chemical maker, Albemarle will be added to the S&P 500 Global Industry Classification Standard (“GICS”) Specialty Chemicals Sub-Industry index. Other changes are also being made to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices.

Earlier this month, Albemarle agreed to divest its Chemetall Surface Treatment unit. The unit will be sold to German Chemical giant, BASF (BASFY - Free Report) in an all-cash transaction worth $3.2 billion. The Chemetall business was acquired by Albemarle in Jan 2015 as part of its $6.2 billion acquisition of Rockwood Holdings Inc.

Albemarle is selling the unit to concentrate on maximizing shareholder returns by investing for growth in its high-priority businesses. The deal is subject to closing conditions but is expected to conclude by end 2016.

This month, Albemarle along with its partner Chicago Bridge & Iron Company N.V. was presented the 2016 Presidential Green Chemistry Challenge Award, by the U.S. Environmental Protection Agency, in collaboration with the American Chemical Society. The companies received this award for the development of the green AlkyClean process technology.

ALBEMARLE CORP Price

ALBEMARLE CORP Price | ALBEMARLE CORP Quote

 

Shares of Albemarle closed 1.3% higher at $84.40 yesterday.

In first-quarter 2016, Albemarle’s adjusted earnings of $1.12 per share surged 40% from the year-ago quarter figure. However, sales of $865.4 million for the quarter dropped 2.1% year over year due to divestures and currency headwinds. Both figures beat the Zacks Consensus Estimate by a wide margin. The company expects full-year 2016 sales in the range of $3.3−$3.8 billion and adjusted earnings in the band of $3.90−$4.25 per share. 

Albemarle currently sports a Zacks Rank #1 (Strong Buy). 

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


BASF SE (BASFY) - free report >>

Albemarle Corporation (ALB) - free report >>

Published in